Reducing Unwarranted Clinical Variation (UCV) Taskforce

Aim

To oversee the development and implementation of a system-wide approachto identify, address and reduce Unwarranted Clinical Variation (UCV).

Benefits

To refine care processes and implement evidence-based models of care tosupport improved patient outcomes.

Summary

UCV is variation that cannot be explained by the condition or the preference of the patient; it is variation that can only be explained by differences in health system performance.

Left unchecked it has the potential to reduce safety, quality, performance effectiveness and efficiency outcomes.

The ACI has invited Chief Executives to nominate clinicians and managers from local teams to assess the clinical variation at a range of hospitals, in partnership with the ACI

The Taskforce has identified four priority areas of variation to address:

  • Stroke
  • Acute Myocardial Infarction (AMI)
  • Fractured hip
  • Low-volume cancer surgeries

Each strategy focuses on improving patient outcomes. 

Background

In 2012, the Bureau of Health Information (BHI) released its annualperformance report, Healthcare in Focus. The report highlighted clinical variationacross the state in 30-day mortality rates for acute myocardial infarction(AMI) and stroke. 

View the Reducing Unwarranted Clinical Variation Taskforce Membership »

Partnerships

Key Dates

Pilot Sites

Implementation Sites

Evaluation

To be determined.

Related Initiatives

Further Details

Contact

Liz Hay
Health Economics and Analysis Manager
liz.hay@health.nsw.gov.au
02 6625 5090

Raj Verma
Director, Clinical Program Design and Implementation
raj.verma@health.nsw.gov.au
02 9464 4605

Page Top | Added: 8 November 2013 | Last modified: 17 November 2013

ACI
Status:
Contact:
Liz Hay
Health Economics and Analysis Manager
Email
02 6625 5090
Share: